Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)

Add time:09/06/2019    Source:sciencedirect.com

High-throughput screening of a small-molecule library identified a 5-triazolo-2-arylpyridazinone as a novel inhibitor of the important glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3). Such inhibitors are of interest due to PFKFB3’s control of the important glycolytic pathway used by cancer cells to generate ATP. A series of analogues was synthesized to study structure-activity relationships key to enzyme inhibition. Changes to the triazolo or pyridazinone rings were not favoured, but limited-size substitutions on the aryl ring provided modest increases in potency against the enzyme. Selected analogues and literature-described inhibitors were evaluated for their ability to suppress the glycolytic pathway, as detected by a decrease in lactate production, but none of these compounds demonstrated such suppression at non-cytotoxic concentrations.

We also recommend Trading Suppliers and Manufacturers of 4,5-DIBROMO-2-METHYL-2H-PYRIDAZIN-3-ONE (cas 13645-74-4). Pls Click Website Link as below: cas 13645-74-4 suppliers

Prev:Synthesis and photochromic properties of 4,5-bisaryl-3(2H)-pyridazinones
Next:Functionalization of the pyridazin-3(2H)-one ring via palladium-catalysed aminocarbonylation)